Symbol="KALA"
AssetType="Common Stock"
Name="Kala Pharmaceuticals Inc"
Description="Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1479419"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100 BEAVER STREET, SUITE 201, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="33163500"
EBITDA="-60114000"
PERatio="None"
PEGRatio="0"
BookValue="10.16"
DividendPerShare="0"
DividendYield="0"
EPS="-14.37"
RevenuePerShareTTM="1.512"
ProfitMargin="0"
OperatingMarginTTM="-24.04"
ReturnOnAssetsTTM="-0.412"
ReturnOnEquityTTM="-2.898"
RevenueTTM="2520000"
GrossProfitTTM="1332000"
DilutedEPSTTM="-14.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="32"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.157"
PriceToBookRatio="2.944"
EVToRevenue="0.0421"
EVToEBITDA="0.0299"
Beta="-1.53"
num_52WeekHigh="56.72"
num_52WeekLow="3.544"
num_50DayMovingAverage="14.95"
num_200DayMovingAverage="13.8"
SharesOutstanding="2348700"
DividendDate="None"
ExDividendDate="None"
symbol="KALA"
open="14.51"
high="14.71"
low="14.00"
price="14.12"
volume="40490.00"
latest_trading_day="2023-08-04"
previous_close="14.35"
change="-0.23"
change_percent="-1.6028%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="35"
trend_strength="Strong Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="132592"
Change_recent_avg="0.01"
Delta_recent_avg="1.18"
Variance_recent_avg="0.59"
Change_ratio_recent_avg="-0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="1143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="560"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_positive_thumbnail_id_1="704"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_positive_thumbnail_id_2="1000"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
